{
  "ticker": "TBPH",
  "company_name": "Theravance Biopharma, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03432793",
      "title": "Drug-Drug Interaction (DDI) Study for TD-9855",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Drug Drug Interaction (DDI)",
      "start_date": "2018-02-28",
      "completion_date": "2018-04-21",
      "enrollment": 0,
      "sponsor": "Theravance Biopharma"
    },
    {
      "nct_id": "NCT01459926",
      "title": "A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Opioid Induced Constipation",
      "start_date": "2011-11",
      "completion_date": "2012-06",
      "enrollment": 0,
      "sponsor": "Theravance Biopharma"
    },
    {
      "nct_id": "NCT01467726",
      "title": "Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Alzheimer's Disease",
      "start_date": "2011-11",
      "completion_date": "2012-01",
      "enrollment": 0,
      "sponsor": "Alfasigma S.p.A."
    },
    {
      "nct_id": "NCT02772159",
      "title": "TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Chronic Obstructive Pulmonary Disease (COPD)",
      "start_date": "2015-06",
      "completion_date": "2016-04",
      "enrollment": 0,
      "sponsor": "Mylan Inc."
    },
    {
      "nct_id": "NCT02709928",
      "title": "Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Adults, Elderly Subjects",
      "start_date": "2016-03",
      "completion_date": "2016-12",
      "enrollment": 0,
      "sponsor": "Theravance Biopharma"
    },
    {
      "nct_id": "NCT01321879",
      "title": "Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Infection, Bacteremia",
      "start_date": "2011-03",
      "completion_date": "2016-12",
      "enrollment": 0,
      "sponsor": "M.D. Anderson Cancer Center"
    },
    {
      "nct_id": "NCT00887406",
      "title": "Study of GSK961081 in Healthy Volunteer Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Pulmonary Disease, Chronic Obstructive",
      "start_date": "2005-11-07",
      "completion_date": "2006-10-04",
      "enrollment": 0,
      "sponsor": "Theravance Biopharma"
    },
    {
      "nct_id": "NCT03555617",
      "title": "Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Inflammatory Bowel Disease",
      "start_date": "2018-06-13",
      "completion_date": "2018-07-15",
      "enrollment": 0,
      "sponsor": "Theravance Biopharma"
    },
    {
      "nct_id": "NCT02578082",
      "title": "Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Renal Impairment",
      "start_date": "2015-12",
      "completion_date": "2016-05",
      "enrollment": 0,
      "sponsor": "Mylan Inc."
    },
    {
      "nct_id": "NCT02663089",
      "title": "A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Pulmonary Disease, Chronic Obstructive",
      "start_date": "2016-02-08",
      "completion_date": "2016-03-17",
      "enrollment": 0,
      "sponsor": "Theravance Biopharma"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1": 28,
      "PHASE2": 12,
      "PHASE4": 2,
      "PHASE3": 4,
      "PHASE2, PHASE3": 1,
      "PHASE1, PHASE2": 2,
      "": 1
    },
    "by_status": {
      "COMPLETED": 44,
      "TERMINATED": 5,
      "RECRUITING": 1
    },
    "active_trials": 1,
    "completed_trials": 44,
    "conditions": [
      "Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects",
      "Acute Lung Injury (ALI) Associated With COVID-19, Inflammatory Lung Conditions Associated With COVID-19",
      "Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)",
      "Alzheimer's Disease",
      "Asthma",
      "Attention-Deficit/Hyperactivity Disorder, ADHD",
      "COPD",
      "COPD (Chronic Obstructive Pulmonary Disease)",
      "COVID-19",
      "Chronic Constipation",
      "Chronic Obstructive Pulmonary Disease (COPD)",
      "Chronic Obstructive Pulmonary Disease, COPD",
      "Constipation",
      "Crohn's Disease",
      "Drug Drug Interaction (DDI)",
      "End-Stage Renal Disease, Stage 5 Chronic Kidney Disease",
      "Enteral Feeding Intolerance",
      "Fibromyalgia",
      "Gastrointestinal Motility Disorder",
      "Gastroparesis",
      "Healthy",
      "Healthy Adults, Elderly Subjects",
      "Healthy, Opioid-induced Constipation",
      "Hepatic Impairment",
      "Hepatitis C, HCV",
      "Infection, Bacteremia",
      "Infections, Bacterial Infections",
      "Inflammatory Bowel Disease",
      "Intestinal Disorder, Bowel Diseases, Inflammatory",
      "Intestinal Disorders, Bowel Diseases, Inflammatory",
      "OIC",
      "Opioid Induced Constipation",
      "Opioid-induced Constipation (OIC)",
      "Pulmonary Disease, Chronic Obstructive",
      "Renal Impairment",
      "Staphylococcal Skin Infection",
      "Symptomatic Neurogenic Orthostatic Hypertension, nOH",
      "Symptomatic Neurogenic Orthostatic Hypotension",
      "Symptomatic Neurogenic Orthostatic Hypotension, MSA, Parkinson's Disease (PD), Pure Autonomic Failure (PAF)",
      "Ulcerative Colitis (UC)",
      "Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:15.940367",
    "search_query": "Theravance Biopharma, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Theravance+Biopharma,+Inc."
  }
}